Immunization Administration - Complete Study Guide

Immunization Administration Deep Dive

Many states now authorize pharmacy technicians to administer vaccines under pharmacist supervision. Even where technicians do not administer vaccines, they are involved in vaccine storage, preparation, documentation, and patient scheduling. This guide covers the knowledge and skills needed for immunization administration.

Legal Authority for Technician-Administered Vaccines

The scope of practice for pharmacy technicians varies by state. Before administering vaccines, a technician must:

Be authorized under state law or regulation.
Complete an approved immunization training program (typically includes CPR certification).
Administer vaccines only under the supervision of a licensed pharmacist.
Maintain current certification and any required continuing education.

Injection Techniques

Intramuscular (IM) Injection

Most vaccines are administered by intramuscular injection. The needle is inserted at a 90-degree angle into the muscle.

Patient	Preferred Site	Needle Gauge	Needle Length
Adults and older children	Deltoid muscle (upper arm)	22-25 gauge	1 to 1.5 inches
Infants (under 12 months)	Vastus lateralis (anterolateral thigh)	22-25 gauge	1 inch
Toddlers (1-2 years)	Vastus lateralis or deltoid	22-25 gauge	1 to 1.25 inches

Subcutaneous (SubQ) Injection

Some vaccines (MMR, varicella) are administered subcutaneously. The needle is inserted at a 45-degree angle into the fatty tissue.

Site: Fatty tissue over the triceps (back of upper arm) or anterolateral thigh.
Needle: 23-25 gauge, 5/8 inch.

Intranasal Administration

FluMist (live attenuated influenza vaccine) is administered as a nasal spray - half the dose in each nostril. No needle is involved.

Before Administering a Vaccine

Screen the patient: Use the appropriate screening questionnaire to identify contraindications and precautions (allergies, pregnancy, immunocompromised status, recent illness).
Provide the VIS: Federal law (National Childhood Vaccine Injury Act) requires that a Vaccine Information Statement (VIS) be provided to the patient (or parent/guardian) before administration. The VIS explains the vaccine's benefits and risks.
Verify the vaccine: Check the drug name, dose, lot number, expiration date, and appearance (clarity, color, no particulate matter unless expected for a suspension).
Prepare the injection site: Clean the site with an alcohol swab and allow it to dry completely before injecting.
Verify patient identity: Confirm the patient's name, date of birth, and that they are receiving the correct vaccine.

During Administration

Use proper aseptic technique.
Administer the vaccine using the correct route, site, and needle size for the patient.
Do not aspirate before IM injections (this is no longer recommended for routine immunizations per CDC/ACIP guidelines).
Administer the full dose.
If giving multiple vaccines, use different injection sites (at least 1 inch apart if using the same limb).

After Administration

Observe the patient: Monitor for at least 15 minutes for signs of an immediate allergic reaction (anaphylaxis). For patients with a history of fainting, monitoring for 15 minutes is especially important.
Dispose of sharps: Place used needles and syringes in an approved sharps container immediately. Do not recap needles.
Document the vaccination: Record the following:
- Vaccine name and manufacturer
- Lot number and expiration date
- Date of administration
- Dose and route
- Injection site
- Name and title of the person who administered the vaccine
- VIS edition date and date provided to the patient
Report to state immunization registry: Many states require pharmacies to report administered vaccines to a state immunization information system (IIS).

Handling Adverse Events

Anaphylaxis

Anaphylaxis is a severe, potentially life-threatening allergic reaction. Signs and symptoms include:

Difficulty breathing, wheezing, throat swelling
Hives, flushing, or generalized rash
Rapid or weak pulse
Dizziness, loss of consciousness
Nausea, vomiting, abdominal cramps

Epinephrine (typically via auto-injector) must be available at every vaccination site and should be administered immediately for suspected anaphylaxis. Call emergency medical services (911) immediately.

VAERS (Vaccine Adverse Event Reporting System)

VAERS is a national system co-managed by the CDC and FDA for monitoring vaccine safety. Healthcare providers are required to report certain adverse events following immunization and are encouraged to report any clinically significant event.

Reports can be submitted online at vaers.hhs.gov.
Reporting helps identify potential safety signals that may not have been detected during clinical trials.

National Vaccine Injury Compensation Program (VICP)

The VICP is a federal no-fault program that compensates individuals who are injured by vaccines covered under the program. Patients do not need to sue the manufacturer - claims are filed with the program.

Vaccine Storage Summary

Most vaccines are stored refrigerated at 2-8 degrees C (36-46 degrees F).
Some vaccines (such as varicella and certain COVID-19 formulations) require freezer or ultra-cold storage.
Use a calibrated digital thermometer with a temperature probe in a glycol-filled bottle (buffered probe) for accurate monitoring.
Record temperatures at least twice daily.
Never store vaccines in the door of a refrigerator or freezer.
Keep vaccines in original packaging to protect from light and help identify products.
Have a written temperature excursion plan in place.

Exam Tips

Know the difference between IM and SubQ injection technique (angle, needle size, site).
The VIS must be provided before every vaccination - this is a federal requirement.
Epinephrine must be available at every immunization site.
Know what VAERS is and who can report to it.
Monitor patients for at least 15 minutes after vaccination.
Do not recap needles - place directly in sharps containers.
Documentation must include vaccine name, lot number, expiration date, site, route, date, and administrator's name.